Compare GPMT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | NSPR |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | 28 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.9M | 72.1M |
| IPO Year | N/A | 2009 |
| Metric | GPMT | NSPR |
|---|---|---|
| Price | $1.41 | $0.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $3.00 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 157.2K | 157.0K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 12.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,310,000.00 |
| Revenue This Year | $458.85 | $57.98 |
| Revenue Next Year | $8.63 | $95.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.24 | $0.69 |
| 52 Week High | $3.12 | $2.93 |
| Indicator | GPMT | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 39.78 | 28.77 |
| Support Level | $1.24 | N/A |
| Resistance Level | $1.58 | $1.04 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 18.87 | 5.72 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.